Previous Page  16 / 18 Next Page
Information
Show Menu
Previous Page 16 / 18 Next Page
Page Background

allied

academies

J Parasit Dis Diagn Ther 2017

Volume 2 Issue 3

Tropical Medicine 2017

Notes:

Page 33

September 7-8, 2017 | Edinburgh, Scotland

4

th

International Conference on

Tropical Medicine, Infectious Diseases & Public Health

QUANTIFICATION OF COLISTIN PLASMA

LEVELS IN CRITICAL PATIENTS FROM

SABANACENTRO, COLOMBIA POPULATION

Diana Gonzalez

a

, Cuervo S

a

and

Bustos RHa Garcia JC

a

a

University of La Sabana, Colombia

A

ntimicrobial resistance to antibiotic treatment has

significantly increased in recent years, causing this to become

a public health problem. More than 70% of pathogenic bacteria

are resistant to at least one of the currently used antibiotics.

Recently, the use of Polymyxin E (Colistin) has been used as a

"last line" therapy in treatment of gram-negative multiresistant

bacteria. However, pharmacological knowledge about these

molecules is very weak, because their use has been discontinued

due to their high toxicity. In recent years, research has focused

on the determination of the pharmacokinetic parameters of

Colistimethate sodium, in order to find the optimal dose to

maintain an adequate benefit-risk balance. The aim of this study

was to determine Colistin plasma levels in patients infected

with multiresistant bacteria, from a Sabana Centro (Colombia)

population, by means of the standardization and validation of

a fast and simple methodology as high-performance liquid

chromatography (HPLC). Our results were standardized by

HPLC, and allowed to measure plasma levels in the study

population. The above, allows to presently guide the dosage of

Sodium Colistimethate, according to Colistin plasma levels.

Biography

Diana González is medical doctor interested in the evaluation of the relationship

between serum levels and therapeutic efficacy in the use of antimicrobial drugs

as well as the determination of antimicrobial resistance in the clinical setting

related to use of these molecules. Currently she is working in the Research

Group Therapeutic Evidence of the Faculty of Medicine of the University of

La Sabana. In addition, they have participated in speeches and conferences

regarding the safe and cost effective use of antimicrobial drugs in Colombia.

dianamaria616@hotmail.com

Diana Gonzalez et al., J Parasit Dis Diagn Ther 2017